Canada markets close in 3 hours 49 minutes

Bioasis Technologies Inc. (BTI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3500-0.0200 (-5.41%)
As of 9:47AM EDT. Market open.

Bioasis Technologies Inc.

14 Water Street
Guilford, CT 06437
United States
203 533 7082

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Deborah Ann Rathjen B.Sc. (Hons.), Q.C., Ph.D., M.A.I.C.D., FTSEExec. Chairman, CEO & Pres105.35kN/A1958
Ms. Christine AntalikChief Financial Officer282.85kN/A1971
Mr. Graeme DickDirector of Investor RelationsN/AN/AN/A
Mr. Kim EltonDirector of MarketingN/AN/AN/A
Mr. Doug Williams MBAExec. VP & Chief Bus. OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the delivery of therapeutics across the blood-brain barrier (BBB); and the treatment of central nervous system disorders, including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-002), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). Bioasis Technologies Inc. was founded in 2007 and is headquartered in Guilford, Connecticut.

Corporate Governance

Bioasis Technologies Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.